Cargando…

06. United States Healthcare Provider Preferences for Adult Pneumococcal Vaccine Recommendations

BACKGROUND: Pneumococcal vaccine recommendations for US adults are complex, varying by age and underlying conditions, and include both 23-valent polysaccharide vaccine (PPSV23) and 13-valent pneumococcal conjugate vaccine. The Advisory Committee on Immunization Practices (ACIP) will vote on new reco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vietri, Jeffrey, Meyers, Kelley, Poulos, Christine, Chilson, Erica, Sweeney, Carolyn, Davis, Kimberly, Snow, Vincenza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645019/ http://dx.doi.org/10.1093/ofid/ofab466.209

Ejemplares similares

Preferences for Adult Pneumococcal Vaccine Recommendations Among United States Health Care Providers
por: Sacco, Patricia, et al.
Publicado: (2019)

1740. Healthcare Providers’ Preferences for Pediatric Pneumococcal Vaccination Recommendations in the United States
por: Vietri, Jeffrey T, et al.
Publicado: (2023)

Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions
por: Vietri, Jeffrey, et al.
Publicado: (2019)

1438. Uptake of 13-Valent Pneumococcal Conjugate Vaccine in High-Risk Adults Aged 19–64 Years: A Kaplan–Meier Approach
por: Vietri, Jeffrey, et al.
Publicado: (2018)

1738. Cost-Effectiveness Analysis of Infant Pneumococcal Vaccination with the 20-Valent Pneumococcal Conjugate in the US
por: Rozenbaum, Mark, et al.
Publicado: (2023)

1404. Twenty-year impact of Pneumococcal Conjugate Vaccines (PCV) on the burden of invasive pneumococcal disease in US children less than 5 years of age
por: Lapidot, Rotem, et al.
Publicado: (2020)

Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children
por: Wasserman, Matt, et al.
Publicado: (2021)

1737. Cost-Effectiveness Analysis of Catch-Up Vaccination with the 20-Valent Pneumococcal Conjugate Vaccine
por: Rozenbaum, Mark, et al.
Publicado: (2023)

Disparities in Uptake of 13-valent Pneumococcal Conjugate Vaccine among Older Adults Following Routine Recommendation in the United States
por: McLaughlin, John, et al.
Publicado: (2017)

Risk of Pneumococcal Disease in US Adults by Age and Risk Profile
por: Grant, Lindsay R, et al.
Publicado: (2023)

Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers’ attitudes and practices
por: Herrera-Restrepo, Oscar, et al.
Publicado: (2022)

Healthcare Providers’ Adherence to Recommended Pneumococcal and Influenza Vaccination in Patients Discharged with Respiratory Diseases from General Medical Wards
por: Alshehri, Amani, et al.
Publicado: (2023)

2656. Eliciting Preferences for Zoster Vaccination in US Adults Aged 50 Years and Older
por: Patterson, Brandon J, et al.
Publicado: (2019)

End-of-life care preferences of the general public and recommendations of healthcare providers: a nationwide survey in Japan
por: Hamano, Jun, et al.
Publicado: (2020)

1442. Pneumonia Hospitalizations Averted With 13-Valent Pneumococcal Conjugate Vaccination of Adults Aged 18–64 Years With Diabetes in the United States
por: Suaya, Jose, et al.
Publicado: (2018)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence
por: Chilson, Erica, et al.
Publicado: (2020)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
por: Gourzoulidis, George, et al.
Publicado: (2023)

Sequential Administration of PCV13 Followed by PPSV23 Results in a More Robust Immune Response in PPSV23-Naïve Adults Age 60–64 Years
por: Chilson, Erica, et al.
Publicado: (2017)

Determinants of healthcare provider recommendations for influenza vaccinations
por: Villacorta, Reginald, et al.
Publicado: (2015)

Cesarean section in Shanghai: women’s or healthcare provider’s preferences?
por: Deng, Wei, et al.
Publicado: (2014)

P06 The 15-valent pneumococcal conjugate vaccine (PCV) V114 induces cross-reactive antibodies against pneumococcal serotype 6C
por: Shi, Yaru, et al.
Publicado: (2023)

Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States
por: McLaughlin, John M., et al.
Publicado: (2019)

Current Recommendations for Pneumococcal Vaccination of Children and Adults
por: Fakhraei, Hossein, et al.
Publicado: (2015)

S06-2 GAP: The Girls Active Project
por: McQuinn, Sara, et al.
Publicado: (2022)

Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
por: Malene B, Mikkelsen, et al.
Publicado: (2023)

Patient and parent preferences for characteristics of prophylactic treatment in hemophilia
por: Furlan, Roberto, et al.
Publicado: (2015)

Health Care Provider Knowledge and Attitudes Regarding Adult Pneumococcal Conjugate Vaccine Recommendations — United States, September 28–October 10, 2022
por: Kahn, Rebecca, et al.
Publicado: (2023)

Immunization with Attenuated Pneumococcal Strains Provides Protection against Pneumococcal Colonization in Humans
por: Narciso, Ana Rita, et al.
Publicado: (2023)

2727. Numbers Needed to Vaccinate for Prevention of Adult Pneumonia with Pneumococcal Conjugate Vaccine: Which Values Should Determine Policy?
por: Gessner, Bradford D, et al.
Publicado: (2019)

Routine patient surveys: Patients’ preferences and information gained by healthcare providers
por: Schöpf, Andrea C., et al.
Publicado: (2019)

iWork '06 with iLife '06
por: Harrington, Richard
Publicado: (2006)

1105 Chronic Kidney Disease and Invasive Pneumococcal Disease in Adults
por: Baxter, Roger, et al.
Publicado: (2014)

Disparities in healthcare providers’ interpretations and implementations of ACIP’s meningococcal vaccine recommendations
por: Huang, Liping, et al.
Publicado: (2019)

A Hepatitis C Educational Needs Assessment of Canadian Healthcare Providers
por: Naghdi, Reza, et al.
Publicado: (2017)

Personalizing pneumococcal vaccination recommendations: The Saudi Thoracic Society guidelines
por: Torres, Antoni
Publicado: (2016)

Understanding healthcare provider preferences for ordering respiratory cultures to diagnose ventilator associated pneumonia: A discrete choice experiment
por: Kenaa, Blaine, et al.
Publicado: (2022)

Minutes of COVAC meeting held on 06.06.1986
Publicado: (1986)

Preferences of healthcare providers for capitation payment in Kenya: a discrete choice experiment
por: Obadha, Melvin, et al.
Publicado: (2020)

Comparing Public and Provider Preferences for Setting Healthcare Priorities: Evidence from Kuwait
por: Alsabah, Abdullah M., et al.
Publicado: (2021)

The role of the media on maternal confidence in provider HPV recommendation
por: Walker, Kimberly K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8kbr75jhome464k998olo4mbjc